지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.12
- 수록면
- 104 - 110 (7page)
이용수
초록· 키워드
오류제보하기
Purpose: Totally implantable venous access ports (TIVAPs) can be used long-term for safe administration of intravenous drugs. TIVAP complications include catheter-related infections, venous thrombosis, extravasation, TIVAP migration, and pain. The relationship between the timing of the first chemotherapy administration after port implantation and complications is controversial. This study aimed to investigate the safety of immediate use of TIVAPs and the associated risk factors for complications.
Methods: Between January 2016 and December 2018, 305 patients (median age, 53 years; 256 women) who underwent TIVAP placement at our institution were included. Chemotherapy was administered within 2 days of implantation. A retrospective analysis of patients’ clinical data was performed to investigate catheter days and complications of TIVAPs.
Results: Overall, 305 patients were evaluated over 57,324 catheter days (median, 168 catheter days; interquartile range, 105). The median interval between placement and first use of TIVAPs was 0.98 days. The overall morbidity rate was 2.95%. Nine complications occurred in nine patients, including TIVAP-related infection (4), pain (2), port occlusion (1), thrombosis (1), and scar disunion (1), of which five required port removal (1.64%). The median number of catheter days before complications occurred was 61 (range, 10–457 days; interquartile range, 51). No complications occurred within 7 days of implantation. Body mass index was an independent risk factor for TIVAP-related complications in the Cox proportional hazards model (multivariable analysis: hazard ratio, 1.221; 95% confidence interval, 1.054–1.414; P=0.008).
Conclusion: This study suggests the safe long-term use of TIVAPs following their immediate chemotherapy administration within 2 days of implantation.
Methods: Between January 2016 and December 2018, 305 patients (median age, 53 years; 256 women) who underwent TIVAP placement at our institution were included. Chemotherapy was administered within 2 days of implantation. A retrospective analysis of patients’ clinical data was performed to investigate catheter days and complications of TIVAPs.
Results: Overall, 305 patients were evaluated over 57,324 catheter days (median, 168 catheter days; interquartile range, 105). The median interval between placement and first use of TIVAPs was 0.98 days. The overall morbidity rate was 2.95%. Nine complications occurred in nine patients, including TIVAP-related infection (4), pain (2), port occlusion (1), thrombosis (1), and scar disunion (1), of which five required port removal (1.64%). The median number of catheter days before complications occurred was 61 (range, 10–457 days; interquartile range, 51). No complications occurred within 7 days of implantation. Body mass index was an independent risk factor for TIVAP-related complications in the Cox proportional hazards model (multivariable analysis: hazard ratio, 1.221; 95% confidence interval, 1.054–1.414; P=0.008).
Conclusion: This study suggests the safe long-term use of TIVAPs following their immediate chemotherapy administration within 2 days of implantation.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (27)
참고문헌 신청
Voog E / 2018 / Totally implantable venous access ports : a prospective longterm study of early and late complications in adult patients with cancer / Support Care Cancer 26:81~89
Vescia S / 2008 / Management of venous port systems in oncology : a review of current evidence / Ann Oncol 19:9~15
Kurul S / 2002 / Totally implantable venous-access ports : local problems and extravasation injury / Lancet Oncol 3:684~692
Kakkos A / 2017 / Complication-related removal of totally implantable venous access port systems : does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients / Eur J Surg Oncol 43:689~695
Narducci F / 2011 / Totally implantable venous access port systems and risk factors for complications : a one-year prospective study in a cancer centre / Eur J Surg Oncol 37:913~918
Vescia S / 2008 / Management of venous port systems in oncology : a review of current evidence / Ann Oncol 19:9~15
Kurul S / 2002 / Totally implantable venous-access ports : local problems and extravasation injury / Lancet Oncol 3:684~692
Kakkos A / 2017 / Complication-related removal of totally implantable venous access port systems : does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients / Eur J Surg Oncol 43:689~695
Narducci F / 2011 / Totally implantable venous access port systems and risk factors for complications : a one-year prospective study in a cancer centre / Eur J Surg Oncol 37:913~918
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
A Classic and Effective Approach for Managing Totally Implantable Venous-Access Port Site Dehiscence in Patients with Cancer: The Limberg Flap
Journal of Wound Management and Research
2024 .06
-
A Peripherally Inserted Central Catheter is a Safe and Reliable Alternative to Short-Term Central Venous Catheter for the Treatment of Trauma Patients
Journal of trauma and injury : JTI
2019 .01
-
혈액투석도관 관련 감염: 예방에서 치료까지
의료관련감염관리
2023 .06
-
Efficacy and Safety of Midline Catheters with Integrated Wire Accelerated Seldinger Technique
Vascular Specialist International
2022 .03
-
An analysis of the outcomes of totally implantable access port implantation performed by surgical residents
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2021 .06
-
Central Venous Catheter
대한인터벤션영상기술학회지
2017 .05
-
Randomized comparison of popliteal-sciatic perineural catheter tip migration and dislocation in a cadaver model using two catheter designs
Korean Journal of Anesthesiology
2017 .01
-
Catheter-associated urinary tract infections in patients who have undergone radical cystectomy for bladder cancer: A prospective randomized clinical study of two silicone catheters (clinical benefit of antibiotic silicone material)
Investigative and Clinical Urology
2022 .05
-
Complications of Central Venous Totally Implantable Access Port: Internal Jugular Versus Subclavian Access
Acute and Critical Care
2015 .01
-
Secondary migration of a pre-existing central venous catheter due to a Swan-Ganz catheter insertion – A case report –
Anesthesia and Pain Medicine
2023 .01
-
Totally implantable venous access device (Port) migration in Patients with Bilateral Mastectomy
대한외과학회 학술대회 초록집
2017 .11
-
Ultrasonographically detected central venous catheter-related thrombosis in patient undergoing anticoagulation therapy during anesthetic induction
Medical Biological Science and Engineering
2018 .07
-
Comparison of in vivo antibacterial and antithrombotic activities of two types of pulmonary artery catheters in pig
생체재료학회지
2017 .12
-
Complications of Central Venous Totally Implantable Access Port:Internal Jugular Versus Subclavian Access
Acute and Critical Care
2015 .01
-
Catheter detection by transthoracic echocardiography during placement of peripherally inserted central catheters: a real-time method for eliminating misplacement
Acute and Critical Care
2024 .05
-
Dislodgement of a Large, Catheter-Related Right Atrial Thrombus
Cardiovascular Imaging Asia
2022 .10
-
Posterior triangle approach for lateral in-plane technique during hemodialysis catheter insertion via the internal jugular vein
Annals of Surgical Treatment and Research
2015 .01
-
간 이식 후 담도 협착 환자에게 시행하는 Large profile catheter insertion에서 Rubber band 고정법에 관한 보고
대한인터벤션영상기술학회지
2016 .05
-
A Retained Epidural Catheter Fragment Treated by Surgery
Asian Spine Journal
2015 .01
-
Central venous catheter malposition due to dialysis catheter -a case report-
Korean Journal of Anesthesiology
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0